_256_384.png)
News | November 21, 2025
in-cosmetics Asia 2025 smashes records, draws global beauty elite
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
The initiative aims to connect startups and tech companies with its business units,
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
